Resource Utilization Associated with Extracardiac Co-morbid Conditions Following Congenital Heart Surgery in Infancy

Krista E Tuomela1, John B Gordon2,1, Laura D Cassidy3,1

  • 1Medical College of Wisconsin, Milwaukee, WI, 53201, USA.

Insights

Congenital heart disease (CHD) with extracardiac co-morbid conditions (ECC) leads to significantly higher healthcare costs and hospital readmissions in infants post-surgery. Managing ECC is crucial for reducing resource utilization and improving outcomes.

Area of Science:

  • Pediatric Cardiology
  • Healthcare Resource Utilization
  • Chronic Co-morbidities

Background:

  • Congenital heart disease (CHD) frequently co-exists with chronic extracardiac co-morbid conditions (ECC).
  • While ECC increases operative resource use, its post-discharge impact on healthcare utilization remains under-described.
  • Understanding ECC's long-term effects is vital for comprehensive CHD management.

Purpose of the Study:

  • To determine the prevalence of chronic ECC in infants with CHD.
  • To evaluate the impact of ECC on healthcare resource utilization for 2 years after index cardiac surgery.
  • To identify factors associated with increased post-discharge resource use.

Main Methods:

  • Retrospective study of infants (<1 year) undergoing cardiac surgery (2006-2011).
  • Data extraction included demographics, diagnoses, STAT score, and ECC.
  • Post-discharge resource utilization (clinic/ER visits, admissions, hospital days, charges) analyzed using Mann-Whitney Rank Sum Test.

Main Results:

  • ECC was present in 55% of infants, associated with higher STAT scores (median 3 vs. 2).
  • Infants with ECC incurred significantly higher hospital charges (median $78K vs. $10K) and unplanned hospital days (median 4 vs. 0).
  • Increased ECC burden correlated with higher resource utilization, independent of surgical complexity.

Conclusions:

  • Chronic ECC significantly increases post-discharge healthcare resource utilization in infants with CHD.
  • Higher STAT scores and multiple ECC are key predictors of increased resource use.
  • These findings support the development of specialized care programs for high-risk pediatric cardiac patients to optimize health and reduce costs.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
405
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
680
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
479